Loading...

Theriva Biologics, Inc.

TOVX•AMEX
Healthcare
Biotechnology
$0.41
$0.15(59.41%)
U.S. Market opens in 16h 22m

Theriva Biologics, Inc. (TOVX) Stock Overview

Explore Theriva Biologics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap15.1M
P/E Ratio-0.12
EPS (TTM)$-2.08
ROE-2.09%
Fundamental Analysis

AI Price Forecasts

1 Month$0.24
3 Months$0.00
1 Year Target$0.00

TOVX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Theriva Biologics, Inc. (TOVX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.12 and a market capitalization of 15.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
64.27%
5-Day Change
72.45%
1-Month Change
118.12%
3-Month Change
133.43%
6-Month Change
26.88%
Year-to-Date (YTD) Change
100.81%
1-Year Change
-67.75%
3-Year Change
-97.62%
5-Year Change
-99.66%
All-Time (Max) Change
-100.00%

Contact Information

https://therivabio.com
301 417 4364
9605 Medical Center Drive, Rockville, MD, 20850

Company Facts

20 Employees
IPO DateDec 18, 2006
CountryUS
Actively Trading

Frequently Asked Questions